UC researchers significantly shorten drug development time

Researchers at the University of Cincinnati College of Medicine and Cincinnati Children’s Hospital have developed a new approach, which combines advanced screening techniques with computational modeling, to significantly shorten the drug discovery process. It has the potential to transform the pharmaceutical industry.

The research, published recently in Science Advances, represents a significant leap forward in drug discovery efficiency. It was featured on LegalReader.com.

The research team was led by Alex Thorman, PhD, co-first author and a postdoctoral fellow in the Department of Environmental and Public Health Sciences in the College of Medicine. They utilized a dual-method approach to streamline the identification of promising drug candidates. The first method involved screening a large database of small molecules called the Library of Integrated Network-based Cellular Signatures (LINCS). This database allowed the researchers to evaluate tens of thousands of potential therapeutic compounds at once, identifying those with the most promising biological activity.

They then used targeted docking simulations, an advanced computational technique that models the interaction between small molecules and their specific protein targets. By combining these two approaches, the team was able to rapidly narrow down the list of potential drug candidates. They reduced the initial screening process to just a few hours.

The improved efficiency could be particularly beneficial in tackling diseases that currently have no cure, including various forms of cancer. 

Thorman also said the ability to shorten discovery could be particularly critical to addressing public health crises, such as pandemics. 

To read the original UC News report on the research, click here.

Featured image at top: Pills of different colors spilling out of bottle. Photo/Provided.